newsfilter
← Latest News
PR Newswire·

NeuroSense to Host Investor Webinar on December 8, 2025

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe...